Universal Health Services Inc header image

Universal Health Services Inc

UHS

Equity

ISIN US9139031002 / Valor 982101

New York Stock Exchange, Inc (2024-09-18)
USD 234.69+1.04%

Universal Health Services Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Universal Health Services, Inc. (UHS) stands as a prominent entity in the healthcare sector, offering a broad spectrum of hospital and healthcare services across the United States, Puerto Rico, and the United Kingdom. With a workforce of approximately 96,700 employees, UHS is committed to enhancing patient care and revolutionizing healthcare delivery. The company's operations encompass 27 Acute Care hospitals and 333 Behavioral Health inpatient facilities, alongside 27 freestanding emergency departments, and 21 outpatient facilities and ambulatory care centers spread over 39 states and Washington, D.C. In addition to its healthcare facilities, UHS extends its services through health insurance plans via Prominence Health and manages a physician network through Independence Physician Management. The company has also shown a commitment to supporting military personnel and their families through its Patriot Support Programs initiative. Furthermore, UHS is actively engaging in technological advancements in healthcare, as evidenced by its expansion of the Oracle Health electronic health record system across its network and its venture into digital health through partnerships and product development, including a Generative AI-powered staffing marketplace aimed at enhancing healthcare staffing solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Income

Universal Health Services, Inc. reported a net income attributable to UHS of $261.8 million, or $3.82 per diluted share, during the first quarter of 2024. This is a significant increase compared to the net income of $163.1 million, or $2.28 per diluted share, reported in the first quarter of 2023.

Revenue Growth

Net revenues for Universal Health Services, Inc. increased by 10.8% to $3.844 billion during the first quarter of 2024, compared to $3.468 billion in the first quarter of 2023. This growth reflects the company's strong performance in its core operations.

Adjusted Net Income

On an adjusted basis, Universal Health Services, Inc.'s net income attributable to UHS was $253.1 million, or $3.70 per diluted share, in the first quarter of 2024. This compares to an adjusted net income of $167.6 million, or $2.34 per diluted share, in the first quarter of 2023.

EBITDA

Universal Health Services, Inc. reported earnings before interest, taxes, depreciation, and amortization (EBITDA net of NCI) of $525.9 million during the first quarter of 2024. This is an increase from $407.3 million in the first quarter of 2023. Adjusted EBITDA net of NCI was $525.8 million in the first quarter of 2024, compared to $421.1 million in the same period of 2023.

Cash Flow and Liquidity

During the first quarter of 2024, Universal Health Services, Inc. generated $396 million in net cash from operating activities, up from $291 million in the first quarter of 2023. As of March 31, 2024, the company had $733 million of aggregate available borrowing capacity under its $1.2 billion revolving credit facility.

Summarized from source with an LLMView Source

Key figures

84.2%1Y
60.8%3Y
54.4%5Y

Performance

25.4%1Y
31.3%3Y
39.8%5Y

Volatility

Market cap

13955 M

Market cap (USD)

Daily traded volume (Shares)

154,346

Daily traded volume (Shares)

1 day high/low

237.19 / 230.03

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

KK Menicon
KK Menicon KK Menicon Valor: 28349340
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%JPY 1,330.00
Nihon Chemical Research KK
Nihon Chemical Research KK Nihon Chemical Research KK Valor: 785030
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%JPY 653.00
Mani KK
Mani KK Mani KK Valor: 1241365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.31%JPY 1,824.00
Nxera Pharma KK
Nxera Pharma KK Nxera Pharma KK Valor: 1892568
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.69%JPY 1,299.00
KK AIN HOLDINGS
KK AIN HOLDINGS KK AIN HOLDINGS Valor: 961399
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.02%JPY 5,116.00
KK Noevir Holdings
KK Noevir Holdings KK Noevir Holdings Valor: 11962363
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%JPY 5,320.00
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.26%GBP 2.35
Kaken Seiyaku KK
Kaken Seiyaku KK Kaken Seiyaku KK Valor: 762167
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%JPY 3,915.00
KK B.M.L
KK B.M.L KK B.M.L Valor: 789977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%JPY 2,678.00
Towa Yakuhin KK
Towa Yakuhin KK Towa Yakuhin KK Valor: 248084
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%JPY 2,958.00